ClinicalTrials.gg
Not yet recruitingNCT07815717Updated Sep 11, 2026

Stabilization Exercises for Young Adults With Habitual Knuckle Cracking

An interventional study of Stabilization Exercise Program in Habitual Knuckle Cracking, sponsored by Borna Farhoomand. Not yet recruiting. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Borna Farhoomand · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Habitual knuckle cracking is a widespread behavior caused by intra-articular pressure changes and gas release in synovial joints; however, its long-term effects on hand sensorimotor function, joint laxity, and overall biomechanics remain debated, with no structured clinical exercise interventions currently established. This prospective, randomized controlled trial aims to evaluate the effectiveness of a 4-week targeted stabilization exercise program focusing on the radiocarpal, metacarpophalangeal (MCP), and proximal interphalangeal (PIP) joints in young adults aged 18 to 30 years with habitual knuckle cracking. Participants are randomly allocated to either an intervention group receiving twice-weekly stabilization training (8 total sessions) or an un-exercised control group. The study hypothesizes that structured joint stabilization exercises will significantly improve wrist and finger joint position sense (proprioception), enhance upper extremity functional performance, and reduce joint laxity compared to the control group.

02

Conditions studied

  • Habitual Knuckle Cracking

Browse trials for

Keywords

  • Joint Instability
  • Proprioception
03

In context

Joint Instability

115 studies on the registry are indexed under Joint Instability; 21 are open to participants now.

This study's planned enrollment of 42 is close to the median of 46 across 58 interventional studies indexed under Joint Instability.

Browse Joint Instability studies →

Lead sponsor

Borna Farhoomand is the lead sponsor of 5 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 30 years,
  • Voluntary agreement to participate and signing the Form following detailed study briefing,
  • Willingness to attend all assessment and intervention sessions.

Exclusion criteria

Exclusion Criteria:

  • Having an occupation that requires intensive or repetitive use of the upper extremities and fingers,
  • History of prior musculoskeletal injury involving the upper extremity or hand,
  • Presence of physical or sensory impairments (such as visual or auditory deficits) that could interfere with study procedures,
  • History of congenital or acquired orthopedic, neurological, or rheumatological conditions affecting hand or wrist range of motion and function,
  • History of hand or wrist trauma requiring medical, conservative, or surgical management within the past 6 months,
  • Presence of active skin lesions in the intervention region, including burns, cellulitis, vesicles, bullae, psoriasis, open or closed wounds, scar tissue, active infection, or ,
  • (BMI) ≥30 or a history of morbid obesity.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Stabilization Exercise Group

    Other: Stabilization Exercise Program

  • No intervention
    Non-Exercise Control Group

Interventions

  • OtherStabilization Exercise Program

    A 4-week supervised hand and wrist stabilization exercise program conducted 2 times per week (8 total sessions, 30-45 minutes per session). The protocol targets the radiocarpal (wrist), metacarpophalangeal (MCP), and proximal interphalangeal (PIP) joints. Exercises focus on enhancing joint position sense (proprioception), motor control, isometric and dynamic stabilization, and balanced muscle co-activation around the digits and wrist complex. Progression is individualized based on participant tolerance, maintaining movements within non-painful ranges to prevent joint strain. All sessions are supervised by a physical therapist.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Joint Position Sense (JPS) Absolute Error at 4 Weeks

    Time frame: Baseline and 4 weeks

  2. Change from Baseline in Joint Laxity

    Time frame: Baseline and 4 weeks

Secondary outcomes

  1. Change from Baseline in Upper Extremity Functional Performance using the QuickDASH questionnaire

    Time frame: Baseline and 4 weeks

  2. Change from Baseline in Pain Intensity on Visual Analog Scale (VAS)

    Time frame: Baseline and 4 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Feb 2027, 4 months later.

Of 36 non-industry interventional studies with no phase under Joint Instability, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 37. This study's planned 4 months is below that.

Counting every sponsor, half of 41 studies reached it within 15 months; a quarter within 7 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2026
First posted
Sep 11, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Feb 25, 2027
CompletionEst.
Mar 28, 2027
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07815717
Lead sponsor
Borna Farhoomand
Responsible party
Borna Farhoomand (MSc, Physiotherapist, Pamukkale University) — Sponsor-investigator
First posted
Sep 11, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Feb 25, 2027 (estimated)
Completion
Mar 28, 2027 (estimated)
Last update
Sep 11, 2026

Study contacts

Borna FARHOOMAND, PT, MSc
Contact
borna.farhoomand@gmail.com
+905449033638

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion